Semble Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
144
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
16
Semble General Information
Description
Developer of a cloud-based clinical system designed to cover all the medical and administration needs of the medical practice. The company's system aggregates, structures, and learns from data to benefit health professionals, patients, and clinical research, enabling practitioners to improve health outcomes for patients.
Contact Information
Website
www.semble.ioCorporate Office
- 7 Bell Yard
- London WC2A 2JR
- England, United Kingdom
Corporate Office
- 7 Bell Yard
- London WC2A 2JR
- England, United Kingdom
Semble Timeline
Semble Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 16-Sep-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 04-Jun-2026 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Accelerator/Incubator | 01-Feb-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 29-Oct-2024 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 19-Jun-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 18-Aug-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 11-Dec-2019 | $2.2M | $3.22M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Aug-2018 | $1.02M | $1.02M | Completed | Generating Revenue |
Semble Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B2 | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series B1 | ||||||||
| Series B1 | ||||||||
| Series A2 | ||||||||
| Series A1 | 686,169 | $0.000135 | $10.13 | $10.13 | 1x | $10.13 | 15.04% | |
| Seed Preferred | 573,300 | $0.000135 | $3.99 | $3.99 | 1x | $3.99 | 12.57% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Semble Signals
Semble Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tech Nation Group | Accelerator/Incubator | |||
| Andreessen Horowitz | Venture Capital | Minority | ||
| Partech | Venture Capital | Minority | ||
| Revaia | Growth/Expansion | Minority | ||
| Grow London | Accelerator/Incubator |
Semble FAQs
-
When was Semble founded?
Semble was founded in 2015.
-
Where is Semble headquartered?
Semble is headquartered in London, United Kingdom.
-
What is the size of Semble?
Semble has 144 total employees.
-
What industry is Semble in?
Semble’s primary industry is Enterprise Systems (Healthcare).
-
Is Semble a private or public company?
Semble is a Private company.
-
What is Semble’s current revenue?
The current revenue for Semble is .
-
How much funding has Semble raised over time?
Semble has raised $67.9M.
-
Who are Semble’s investors?
Tech Nation Group, Andreessen Horowitz, Partech, Revaia, and Grow London are 5 of 16 investors who have invested in Semble.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process